COVID-19 in LMIC
Meeting category
Date(s)
3 Nov 2022 - 4 Nov 2022
Meeting type
Virtual Meeting
Organizer

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022

Related Enduring Materials

Enduring Materials

The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so

Day 1 - Thursday, 3 November 2022

Session 1: COVID-19 Therapeutics and Clinical Management in LMICs -
COVID-19 Therapeutics Accessible in LMICs for Inpatients and Outpatients
Tariro Makadzange, MD, PhD
CRMG and Mutala Research, Zimbabwe; Stanford School of Medicine and Stanford Center for Innovation in Global Health, United States
Clinical Management of COVID-19 in High-risk Populations
Claudia Cortes, MD
University of Chile, Chile
Clinical Management of Long COVID
Carlos del Rio, MD
Emory School of Medicine & Grady Health System, United States
Oral Abstract Presentation #1: Viral dynamics and factors favouring the duration of covid-19 positivity: Evidence from the first-three epidemiological waves in Cameroon
Aurelie Minelle Kengni Ngueko
Cameroon
Oral Poster Session -
Exploring Community Rumors and Misinformation about COVID-19 Vaccines among Adults in South Africa (P#1)
Mamakiri Mulaudzi
South Africa
Behavioral Intervention for PLWHA with Ambivalent Attitudes towards the COVID-19 Vaccine (P#2)
Ana-Maria Schweitzer
Romania
Have Attitudes of PLWHA Enrolled at Baylor Black Sea Foundation towards the COVID-19 Vaccination Changed over Time? (P#3)
Elena Melinte-Rizea
Romania
Seroprevalence of SARS-CoV-2 Antibodies in The Catholic University Of Central Africa-School Of Health Sciences At Messa-Yaounde (P#5)
Ariane Claude Fouda
Cameroon
Session 2: Vaccine and Prevention in LMICs -
Vaccine Landscape
Kathryn Stephenson, MD, MPH
Harvard Medical School / Ragon Institute / Beth Israel Deaconess Medical Center, United States
A Multinational Delphi Consensus to End the COVID-19 Public Health Threat
Jeffrey V. Lazarus, PhD, MIH, MA
Barcelona Institute for Global Health (ISGlobal), Spain and CUNY Graduate School of Public Health and Health Policy, New York
Day 2 - Friday, 4 November 2022
Session 3: Long-term Impact of COVID-19 on Health Care Systems in LMICs -
The Omicron Variant: Lessons Learned & Preparedness for Next Waves
Laila Woc-Colburn, MD, DTM&H, FIDSA
Emory University School of Medicine, United States
Early COVID-19 Antivirals Are a Priority for LMICs
Memory Mapfumo, MD, MPH
Africa Centers for Disease Control and Prevention, Ethiopia
Session 4: COVID-19 Diagnostics -
Diagnostic Innovations for COVID-19 Response
Elena Ivanova Reipold, MD, PhD
Foundation for Innovative New Diagnostics (FIND), Switzerland
Genomic Surveillance and Lessons Learned from LMICs
Sikhulile Moyo, MSc, MPH, PhD
Botswana Harvard AIDS Institute Partnership / Harvard T.H. Chan School of Public Health, Botswana
Oral Abstract Presentation #3: SARS-CoV-2 Genomic Surveillance and Reliability of PCR Point Mutation Assay (EscapePLEX kit) for the Rapid Detection of Variants of Concern in Cameroon
Davy Hyacinthe Gouissi Anguechia
Cameroon
Oral Abstract Presentation #5: High seroprevalence of anti-SARS-CoV-2 antibodies in the capital city of Chad
Deutou Wondeu Andrillene Laure
Cameroon
Overview
What's New
  • Registrations of Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2023 is now open. Registration fees are waived for HCPs and Academia Representatives. Please visit the website here for more information and click here to register to the 2023 edition.

  • To stay updated on the relevant developments, make sure you are signed up for our newsletter

About this Program

The Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022 successfully took place on 3 - 4 November 2022 as a virtual program.

The COVID-19 pandemic has had a devastating toll worldwide. In particular, large surges in COVID-19 caseloads have been associated with rapidly escalating demands on hospital staff, beds, supplies, and medical equipment availability. It has been suggested that a portion of COVID-19 deaths may be attributed to hospitals strained by surging caseloads. This can have far-reaching implications for hospital preparedness and for public health authorities on how to allocate resources and improve the clinical management of COVID-19 patients, and it may be even more relevant for low- and middle-income countries (LMICs). Indeed, LMICs face additional challenges, considering their health infrastructures and resources, the difficulty to implement proper social distancing, their challenges with access to vaccines and to diagnostic tests.

As a matter of fact, COVID-19 has created significant challenges for health care systems and community in LMICs. The appropriate diagnosis and clinical management of patients are of utmost importance to avoid complications and poor outcomes. However, the lack of diagnostic tests and some of the basics, such as mechanical ventilation and oxygen supplies in ICUs, but also personal protective equipment for the health care provider in LMICs are staggering. Furthermore, most LMICs still face challenges in the access and rolling-out of COVID-19 vaccines to their populations. In fact, only 0.8 % of vaccines have been administered in low-income countries. Moreover, many of the COVID-19 therapeutics that has been studied in resource-rich setting, are not accessible for patients in LMICs.

Therefore, there is a huge need for knowledge exchange discussing how to handle COVID-19 surges, how to prepare these countries to receive COVID-19 vaccines, diagnostic tests, and other basics in Low- and Middle-income Countries. The Approaches to combat COVID-19 in Low- and Middle-income Countries (LMICs) workshop focuses on the regional specific challenges in the clinical management of COVID-19, public health, prevention strategies, and vaccines rollout. The first edition of the workshop was attended by 402 participants from 90 countries. 97% of them agreed that this program increased their knowledge of regional challenges that LMICs countries face combatting the COVID-19 pandemic, and 92% of attendees indicated that they would be able to implement the gained knowledge highlighting the impact of this program.

Program Chair
General Information 
Who Should Attend?
- Infectious disease clinicians, clinical virologists, primary care physicians, intensivists, microbiologists pulmonologists, epidemiologists, specialized nurses;
- Public health officials;
- Researchers; and
- Community representatives.
Meeting Objectives
The program will cover the following topics:

- Clinical management of COVID-19 in resource limited settings;
- Diagnostic challenges;
- Vaccine challenges in LMICs;
- Treatments for inpatients and outpatients;
- Public health and surveillance.

Our goal is to gather healthcare professionals, public health experts, policymakers, and community representatives from LMICs, and provide a platform to discuss the clinical management, public health challenges and lessons learned from previous waves of infections in LMICs. This will be done in the unique context of the COVID 19 pandemic in Low- and Middle-income countries, considering regional differences in access to medications, health system capacity, and public measures.
Learning Objectives
At the completion of the program participants will be able to:

- Define diagnostic challenges in LIMCs and their impact on regional/international travel;
- Identify accessible therapeutic options and relevant challenges for COVID-19 outpatients and inpatients in LMICs;
- Apply the clinical management and management of complications resulting from COVID-19 infections;
- Summarize challenges associated with COVID-19 vaccination in LMICs; and
- Distinguish which surveillance and public health measures are effective in LMICs.
Practical Information 

We trust that the following information will assist you in organizing your participation for the Workshop on Approaches to Combat COVID-19 in Low- and Middle-income Countries.

Certificate of Attendance
A digital certificate of attendance will be sent to participants that have successfully completed the program and post-meeting survey.
Language
The official language of the workshop is English
Translation will not be provided.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and Insurance
By registering for the workshop, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.

Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Committee
Organizing Committee
Support
Gold Level Support
Support Our Initiative

Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and community representatives involved in COVID-19.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
 
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Ms. Federica Ressa at federica@amededu.com or call +31 30 230 7140.
 
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

  • Symposium opportunities
  • Non-commercial interviews with company representatives
  • Verbal acknowledgment during the program 
  • Discounted and complimentary registrations for your representatives
  • Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
  • Digital and printed advertising opportunities 
  • Social media shout-outs

*Subject to the support level.

Endorsers
The Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop was endorsed by the following societies and organizations:
Previous Editions
Top-Rated Materials from Previous Editions

Use of COVID-19 Therapeutic Options Accessible in LMIC for Outpatients and Inpatients - Brenda Crabtree Ramirez, MD

Approaches to Combat COVID-19 in Low- and Middle-Income Countries 2021

Language
Ratings previous edition
Content is relevant to my practice
4.7
(216)
Content was free from commercial bias
4.8
Overall event experience
5.0